 This news release is not for distribution or dissemination in the United States of America TORONTO, ON ACCESSWIRE April 5, 2021 GreenBank Capital Inc. CSE:GBCOTCMKTS:GRNBFFRA:2TL GreenBank or the Company is very pleased to announce that following its previously announced commercial agreement to acquire a shareholding in, and provide merchant banking services to, Pharmakure, Pharmakure has successfully raised 4m C7m. Some of the proceeds of the fundraising were used to acquire the Business and Assets of CynapseDx Ltd CDX whose breakthrough biomarker technology is expected to dramatically enhance and complement PharmaKures technology for the treatment of patients suffering Alzheimers Disease and Related Dementias ADRD. 